These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 5960880
1. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase. Gorkin VZ, Gridneva LI, Klyashtorin LB, Veryovkina IV, Vina I. Experientia; 1966 Mar 15; 22(3):157. PubMed ID: 5960880 [No Abstract] [Full Text] [Related]
2. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method. Bartonícek V. Med Pharmacol Exp Int J Exp Med; 1967 Mar 15; 16(2):142-6. PubMed ID: 5298397 [No Abstract] [Full Text] [Related]
3. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy. Hendley ED, Snyder SH. Nature; 1968 Dec 28; 220(5174):1330-1. PubMed ID: 5701350 [No Abstract] [Full Text] [Related]
4. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Neff NH, Yang HY. Life Sci; 1974 Jun 01; 14(11):2061-74. PubMed ID: 4603266 [No Abstract] [Full Text] [Related]
5. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat. Egashira T, Ekstedt B, Kinemuchi H, Wiberg A, Oreland L. Med Biol; 1976 Aug 01; 54(4):272-7. PubMed ID: 957813 [Abstract] [Full Text] [Related]
6. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Garrick NA, Murphy DL. Psychopharmacology (Berl); 1980 Aug 01; 72(1):27-33. PubMed ID: 6781004 [No Abstract] [Full Text] [Related]
7. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A. Hurst JH, Kulakowski EC. Life Sci; 1986 Oct 20; 39(16):1471-7. PubMed ID: 2430159 [Abstract] [Full Text] [Related]
8. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase. Mantle TJ, Wilson K, Long RF. Biochem Pharmacol; 1975 Nov 15; 24(22):2031-8. PubMed ID: 1212252 [No Abstract] [Full Text] [Related]
9. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo. Gorkin VZ, Romanova LA. Biochem Pharmacol; 1968 Jun 15; 17(6):855-60. PubMed ID: 5661349 [No Abstract] [Full Text] [Related]
10. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration. Ali B, Parmar SS, Seth PK, Brumleve SJ. Res Commun Chem Pathol Pharmacol; 1973 Nov 15; 6(3):1083-6. PubMed ID: 4760882 [No Abstract] [Full Text] [Related]
11. [Studies on monoamine oxidase. (Report 37) Effects of oxygen concentration on rat liver and brain monoamine oxidase (author's transl)]. Nakagawa K. Nihon Yakurigaku Zasshi; 1977 Apr 15; 73(3):297-305. PubMed ID: 21126 [Abstract] [Full Text] [Related]
17. The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro. Clineschmidt BV, Horita A. Biochem Pharmacol; 1969 May 15; 18(5):1011-20. PubMed ID: 4389278 [No Abstract] [Full Text] [Related]
18. Monoamine oxidase activity measurements using radioactive substrates. Jain M, Sands F, Von Korff RW. Anal Biochem; 1973 Apr 15; 52(2):542-54. PubMed ID: 4698849 [No Abstract] [Full Text] [Related]
19. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase. Fuller RW. Arch Int Pharmacodyn Ther; 1968 Jul 15; 174(1):32-7. PubMed ID: 4386711 [No Abstract] [Full Text] [Related]